Biomarker Card
This biomarker card gives comprehensive information about each biomarker.
| Detailed Information | |
|---|---|
| Biomarker ID | 116 |
| PMID | 17977648 |
| Year | 2008 |
| Biomarker | PP2A |
| Biomarker Basis | Expression Based |
| Biomolecule | mRNA |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Downregulated in PCa |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways Include:- TSGA14 |
| Experiment | Benign Prostatic Hyperplasia (BPH) vs Prostate Cancer (PCa) |
| Type of Biomarker | Diagnostic |
| Cohort | 35 patients with Benign Prostatic Hyperplasia and 35 patients with Prostate cancer were compared. |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p=0.0073 |
| Method Used | Immunohistochemistry |
| Clinical | No |
| Remarks | Only PP2A gene was validated on human patient cohort |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | PP2A |